Solitron Devices doubles revenue on AMRAAM backlog surge
Solitron Devices, the West Palm Beach-based manufacturer of solid-state semiconductor components for military and aerospace applications, has reported a 101% year-on-year jump in net sales for its fiscal 2027 first quarter, rising from $2.70 million to $5.44 million for the three months ended 31 May 2026. The company swung from a net loss of $0.34 million in the equivalent period last year to net income of $0.99 million, or $0.46 per share, underscoring how a sustained defence procurement cycle is translating into hard earnings for the niche component suppliers that sit deep inside Western weapons programmes.
The numbers reflect a backlog that stood at $23.34 million at quarter end, up 28% from $18.26 million a year earlier. That figure excludes a $5.04 million order received by subsidiary Micro Engineering Inc. (MEI) after the quarter closed, which lifts the company's effective backlog to approximately $26.97 million as of July 2026. CEO Tim Eriksen said the company anticipates sales to "continue to be at this level or greater for the remainder of the 2027 fiscal year."
AMRAAM ramp and the Pentagon's unfunded priorities
The single most consequential signal in the release sits outside the income statement. The US Air Force has placed the Advanced Medium-Range Air-to-Air Missile (AMRAAM) on its unfunded priorities list, requesting that annual production be doubled from 1,200 to 2,400 units by 2028. Solitron identifies AMRAAM as its largest defence programme by revenue exposure. Any production ramp of that scale would flow through a long chain of component and sub-assembly suppliers before a missile leaves the factory, and Solitron sits at that upstream end.
The caveat is significant: unfunded priorities list requests require Congressional approval, and the company is careful to note there is no assurance that approval will materialise. Defence procurement timelines are notoriously elastic. Eriksen flagged that the next AMRAAM order is expected in the fiscal third quarter, while also noting that multi-year orders for components on Standard Missiles 2 and 6 remain a possibility. A confirmed multi-year contract would materially de-risk the revenue trajectory and likely attract renewed institutional attention to a stock that currently trades on the OTC Pink market.
Strategic review adds a corporate catalyst
Separately, Solitron disclosed that it has retained an investment banker to explore strategic alternatives, a disclosure that typically signals openness to a merger, acquisition, or asset sale. The company was explicit that no specific transaction is under consideration, and that further announcements will only be made if the board approves a specific course of action. For a company with $27.6 million in total assets, minimal debt relative to equity, and a balance sheet carrying $6 million in cash, the exercise is worth watching: defence-grade semiconductor manufacturing capacity is a scarce asset in a supply-chain environment where Western governments are actively seeking to onshore or ally-shore critical components.
The broader read-across matters for cross-sector investors. The same geopolitical pressure that is driving AMRAAM production targets upward is also reshaping capital flows into defence-adjacent technology, from power electronics and semiconductor packaging to embedded systems and ruggedised compute. Mid-tier suppliers like Solitron, historically invisible to macro capital allocators, are increasingly the bottleneck that determines whether a programme runs on time. As sovereign governments and prime contractors look to secure supply chains for next-generation weapons systems, the acquisition premium attached to verified, qualified military component manufacturers is rising. The strategic review, whatever its outcome, is a data point in that larger trend.